Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2026-06-01 19:49:09 ET · period of report 2026-06-01 · accession 0001628280-26-039653 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-01 19:49 | 2026-06-01 | MDGL | Soergel David | Chief Medical Off | S - Sale | $495.74 | -1,042 | 10.0K | -9% | -$516.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | S | D | 1,042 | $495.74 | 10,033 | D | — | — | (F1) This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2026. |